[{"NetIncomeLoss_1_Q2_USD":-19648000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-9000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":26100000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-13939000.0,"Depreciation_2_Q2_USD":1275000.0,"Depreciation_1_Q2_USD":700000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":78000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":34000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":13000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2572000.0,"AssetsCurrent_0_Q2_USD":128511000.0,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":18000.0,"TreasuryStockShares_0_Q2_shares":21.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4721160.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2497000.0,"CommonStockSharesIssued_0_Q2_shares":32706863.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":68771000.0,"Assets_0_Q2_USD":137879000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-7000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-5000.0,"ShareBasedCompensation_2_Q2_USD":4619000.0,"ShareBasedCompensation_1_Q2_USD":2546000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4721160.0,"CommitmentsAndContingencies_0_Q2_USD":null,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":48000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":32636.0,"UnbilledReceivablesCurrent_0_Q2_USD":657000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":33712000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17378000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":18301000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-7981000.0,"CommonStockValue_0_Q2_USD":33000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":47713000.0,"ImpairmentOfInvestments_2_Q2_USD":0.0,"OtherAssetsCurrent_0_Q2_USD":11000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-36654000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-19653000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":622000.0,"OtherAssetsNoncurrent_0_Q2_USD":531000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":56779000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":369133000.0,"Liabilities_0_Q2_USD":26989000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-7000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-5000.0,"Dividends_23_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12183000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6685000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":32076.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":324000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInAccountsAndOtherReceivables_2_Q2_USD":-2000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2649000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-273000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":126000.0,"CommonStockSharesOutstanding_0_Q2_shares":32659740.0,"RestrictedCashNoncurrent_0_Q2_USD":1092000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":51785000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":7211000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":4000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2546000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-34047000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q2_USD":242000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2424000.0,"LiabilitiesCurrent_0_Q2_USD":22510000.0,"DeferredRevenueCurrent_0_Q2_USD":9900000.0,"AccountsPayableCurrent_0_Q2_USD":4498000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2304000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":56779000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-47000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":57871000.0,"InterestReceivable_0_Q2_USD":166000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":59000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7745000.0,"NetIncomeLoss_2_Q2_USD":-36647000.0,"MarketableSecurities_0_Q2_USD":68771000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1193000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-258267000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":9170000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1773000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OperatingIncomeLoss_2_Q2_USD":-36725000.0,"OperatingIncomeLoss_1_Q2_USD":-19682000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":137879000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1972000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":1000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":14956000.0,"OperatingExpenses_2_Q2_USD":45895000.0,"OperatingExpenses_1_Q2_USD":24063000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":397000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.14,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.6,"ProfitLoss_2_Q2_USD":-36647000.0,"OtherLiabilitiesCurrent_0_Q2_USD":42000.0,"StockholdersEquity_0_Q2_USD":110890000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":827000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":68780000.0,"LeaseIncentivePayableCurrent_0_Q2_USD":469000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-195000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":1662000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":4381000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":669000.0,"Ticker":"FULC","CIK":"1680581","name":"FULCRUM THERAPEUTICS, INC.","OfficialName":"Fulcrum Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"518124504.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]